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Mutations in ECEL1 Cause Distal Arthrogryposis Type 5D
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Distal arthrogryposis (DA) syndromes are the most common of the heritable congenital-contracture disorders, and ~50% of cases are
caused by mutations in genes that encode contractile proteins of skeletal myofibers. DA type 5D (DA5D) is a rare, autosomal-recessive
DA previously defined by us and is characterized by congenital contractures of the hands and feet, along with distinctive facial features,
including ptosis. We used linkage analysis and whole-genome sequencing of a multiplex consanguineous family to identify in endothe-
lin-converting enzyme-like 1 (ECEL1) mutations that result in DA5D. Evaluation of a total of seven families affected by DA5D revealed in
five families ECEL1mutations that explain ~70% of cases overall. ECEL1 encodes a neuronal endopeptidase and is expressed in the brain
and peripheral nerves. Mice deficient in Ecel1 exhibit perturbed terminal branching ofmotor neurons to the endplate of skeletal muscles,
resulting in poor formation of the neuromuscular junction. Our results distinguish a second developmental pathway that causes
congenital-contracture syndromes.Distal arthrogryposis (DA) is a group of at least ten disor-
ders characterized by nonprogressive, congenital contrac-
tures that typically affect the hands, feet, wrists, and
ankles.1 Over the past decade, mutations causing DA1
(MIM 108120),2,3 DA2A (Freeman-Sheldon syndrome
[MIM 193700]),4 DA2B (Sheldon-Hall syndrome [MIM
601680]),2,3 and DA7 (trismus pseudocamptodactyly
[MIM 158300])5,6 have been identified in six genes, each
of which encodes a component of the contractile appa-
ratus of skeletal myofibers. Of the DA syndromes for which
no causative mutation has yet been discovered, DA5 (DA
with ophthalmoplegia [MIM 108145])1 is perhaps the
most notable because, unlike the other DA disorders, the
extraocular muscles of the eye are often involved. Since
the original delineation of DA5, the spectrum of ocular
defects observed in affected individuals has expanded
substantially. Additionally, it has become clear that oph-
thalmoplegia is sometimes not present in all affected
members of a family. Furthermore, a subset of affected
individuals develop restrictive lung disease with resultant
hypoxemia, hypercarbia, pulmonary hypertension, and
early death.7
In an effort to delineate genetically homogeneous
subsets of DA5-affected families for gene-discovery studies,
we categorized the phenotypic and mapping data from 35
DA5-affected families into one of four different subtypes of
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DA5D) consisting of severe camptodactyly of the hands,
including adducted thumbs and wrists; mild camptodac-
tyly of the toes; clubfoot and/or a calcaneovalgus defor-
mity; extension contractures of the knee; unilateral ptosis
or ptosis that was more severe on one side; a round-shaped
face; arched eyebrows; a bulbous, upturned nose; and
micrognathia (Figure 1, Table 1, and Figures S1 and S2,
available online). The presence of ophthalmoplegia was
notably absent from this phenotype. Furthermore, unlike
in other DA phenotypes described to date, no parent-to-
child transmissions were reported, and the fact that fami-
lies had multiple affected siblings suggested that, unlike
all other DA phenotypes described to date, DA5D is an
autosomal-recessive disorder.
To identify causative mutations for DA5D, we first
screened each proband by Sanger sequencing genes in
which mutations are known to cause similar DA disorders;
these genes included TPM2 (MIM 190990), TNNT3 (MIM
600692), TNNI2 (MIM 191043), and MYH3 (MIM
160720). We also screened CHRNG (MIM 100730), muta-
tions in which cause congenital contractures and pterygia
in Escobar syndrome (MIM 265000).8 Additionally, each
proband was screened for copy-number variations
(CNVs) by genome-wide array-based comparative genomic
hybridization. No pathogenic mutations or CNVs were
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Figure 1. Pedigree and Clinical Features of Family A
Pedigree showing the relationships and affected status of family A. Typical features of the face include unilateral ptosis, a round-shaped
face, a small jaw, a bulbous upturned nose, and arched eyebrows. Camptodactyly and severely adducted thumbs are also present. Case
identifiers A:V-1 (images A andD), A:IV-6 (images B and E [left]), and A:IV-5 (images C and E [right]) correspond to those in Table 1, where
a detailed description of each individual is provided. The proband is indicated with an arrow. Asterisks indicate individuals in whom
whole-genome sequencing (WGS) was performed. Red dots indicate individuals from whom genotype data were included in analysis
of linkage under a recessive model. Open red squares indicate individuals who were included in the recessive model and from whom
genotype data were unavailable. Blue dots indicate individuals from whom genotype data were included in analysis of linkage under
a dominant model. Open blue squares indicate individuals who were included in the dominant model and from whom genotype
data were unavailable. Larger and more detailed images are presented in Figures S1 and S4.review boards of the University of Washington and Seattle
Children’s Hospital, and informed consent was obtained
from participants or their parents. Subsequently, we
selected three families in which recurrence among siblings
was observed (families A, B, and C in Figure S2) for whole-
genome sequencing (WGS). To prioritize variants identi-
fied via WGS, we genotyped all of the living affected indi-
viduals and their parents in family A (Figure 1) by using the
HumanCytoSNP-12 DNA Analysis BeadChip, which inter-
rogates ~300,000 SNPs. Self-reported East Indian ancestry
was confirmed with EIGENSTRAT.
In family A (Figure 1), the proband (V-1) had unaffected
nonconsanguineous parents, whereas the two affected
aunts (IV-5 and IV-6) and a deceased affected uncle (IV-2)
were born to parents who were double first cousins. This
observation suggested that the father of the proband
(IV-3) was either cryptically related to the proband’s
mother (IV-4) and carried the same mutation as other
familymembers or that he was a carrier for a different path-
ogenic variant in the same gene. An alternative explana-
tion was the presence of maternal isodisomy of the region
containing the causal variant in proband IV-3. To test
whether IV-3 was cryptically related to other family
members, we constructed a pedigree that modeled the
father of the proband (IV-3) as the great grandchild of I-3
and I-4; this would have permitted cotransmission of the
same recessive variant to all affected individuals in the
pedigree (Figure S3).
Under this model, we performed parametric linkage
analysis in ALLEGRO by using a fully penetrant rare reces-
sive model (f1¼ 0; f2¼ 1; q¼ 0.0001) and allele frequencies
estimated from unrelated members of the HapMap GIHThe Americ(Gujarati Indians in Houston, Texas) population on
a ~0.02 cM SNP map. No linkage peaks were observed in
this analysis, suggesting that no homozygous genomic
regions were inherited identically by descent and shared
by both the proband and his affected aunts. This
confirmed that either the causal variant in the unaffected
carrier father existed on a different haplotype background
than that of other family members (e.g., the proband was
a compound heterozygote, whereas the affected siblings
in the fourth generation were homozygous for the causal
variant) or that the common haplotype was too small to
be detected on our SNP map.
To test whether IV-3 contributed a different pathogenic
variant, we performed parametric linkage analysis as
above in only the two affected sibling aunts and their
consanguineous parents (Figure 1). This analysis identified
approximately 82 Mb of genomic regions showing
evidence of linkage with DA5D. To model the additional
information present if IV-4 transmitted a single copy of
a causal haplotype to V-1, we performed linkage analysis
under a dominant model (f0 ¼ 0; f1 ¼ 1; q ¼ 0.0001) in
the full pedigree (Figure 1). Comparing results from both
analyses (e.g., combining the recessive and dominant
modeling of linkage or a ‘‘redominant’’ model) revealed
only three genomic regions that overlapped and narrowed
the candidate interval to 16.7 Mb.
Next, WGS was performed on each of the selected fami-
lies. In brief, 1 mmof genomic DNAwas subjected to a series
of shotgun-library-construction steps, including fragmen-
tation through acoustic sonication (Covaris), end polish-
ing (NEBNext End Repair kit), A-tailing (NEBNext dA
Tailing kit), and ligation of 8 bp barcoded sequencingan Journal of Human Genetics 92, 150–156, January 10, 2013 151
Table 1. Mutations and Clinical Findings of Individuals with DA5D
Family A Family B Family D Family E Family F
A:V-1 A:IV-5 A:IV-6 B:II-2 B:II-3 D:II-2 D:II-3 E:II-2 F:II-3
Mutation Characteristics
Exon (ECEL1) 2 2 2 2 4 3 4 3 7 6 7 6 6 2 7
Nucleotide
(cDNA)
c.716dupA c.344_
355 del
c.716dupA c.716dupA c.869A>G c.797_
801delins GCT
c.869A>G c.797_
801delins GCT
c.1252C>A c.1184þ3A>T c.1252C>A c.1184þ3A>T c.1184G>A c.590G>A c.1252C>T
GERP score NA NA NA NA 5.51 NA 5.51 NA 5.18 3.07 5.18 3.07 4.84 4.12 5.18
Protein
alteration
p.Tyr239* p.Asn115_
Ala118 del
p.Tyr239* p.Tyr239* p.Tyr290Cys p.Asp266-
Glyfs*15
p.Tyr290Cys p.Asp266-
Glyfs*15
p.Arg418Ser  p.Arg418Ser  p.Arg395Gln p.Gly197Asp p.Arg418Cys
Predicted
effect
premature
truncation
deletion premature
truncation
premature
truncation
missense frameshift missense frameshift missense splice site missense splice site missense missense missense
Genotype heterozygous heterozygous homozygous homozygous heterozygous heterozygous heterozygous heterozygous heterozygous heterozygous heterozygous heterozygous homozygous heterozygous heterozygous
Inheritance maternal paternal maternal/
paternal
maternal/
paternal
maternal paternal maternal paternal maternal paternal maternal paternal NA maternal paternal
Clinical Findings
Ancestry Indian and
eastern
European
Indian Indian European
American
European
American
European
American
European
American
Indian European
American
Consanguineous
parents
no double first
cousins
double first
cousins
no no no no no no
Foot and/or toe
contractures
 þ þ þ þ þ þ þ þ
Ankle
contractures
þ þ þ þ þ þ þ þ þ
Knee
contractures
þ flexion þ flexion þ flexion þ extension þ extension þ extension þ extension þ extension 
Hip contractures þ þ þ þ þ þ þ þ þ
Hand and/or
finger
contractures
þ þ þ þ þ þ þ þ þ
Wrist
contractures
þ þ þ þ þ þ þ þ þ
Elbow
contractures
þ þ þ ND ND ND ND þ þ
Shoulder
contractures
þ þ þ þ ND ND ND þ þ
Neck
contractures
þ þ ND ND ND ND ND þ þ
Ptosis R R R BL (mild) R R  R BL (severe)
Bulbous nose þ þ þ þ þ þ þ þ þ
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The Americadaptors (Enzymatics Ultrapure T4 Ligase). Libraries were
automatically size selected for fragments 350–550 bp in
length with the automated PippinPrep cartridge system,
which provides for fine control over the insert size and
physically isolates each size fraction in separate chambers.
Prior to sequencing, the library was amplified via PCR
(Kapa HiFi Hotsart). For facilitating optimal flow-cell
loading, the library concentration was determined by trip-
licate quantitative PCR (Kapa Illumina Library Quantifica-
tion kit), and molecular-weight distributions were verified
on the Agilent Bioanalyzer. Massively parallel sequencing
by synthesis with fluorescently labeled, reversibly termi-
nating nucleotides was carried out on the HiSeq sequencer.
Samples were sequenced to an average depth of at least
303 with paired-end 100 bp reads; a third read sequenced
the 8 bp index for confirmation of sample assignments.
Demultiplexed BAM files were aligned to a human refer-
ence (hg19) with the Burrows-Wheeler Aligner.9 Read data
from a flow-cell lane were treated independently for align-
ment and quality-control purposes in instances where the
merging of data from multiple lanes was required. All
aligned read data were subjected to: (1) removal of dupli-
cate reads, (2) indel realignment with the Genome Analysis
Toolkit (GATK) IndelRealigner, and (3) base-quality recali-
bration with GATK TableRecalibration. Variant detection
and genotyping were performed with the UnifiedGeno-
typer tool from GATK (v.1.529). Variant data for each
sample were formatted (variant call format [VCF]) as
‘‘raw’’ calls that contained individual genotype data for
one or multiple samples and were flagged with the filtra-
tion walker (GATK) for marking sites that were of
lower quality and potential false positives (e.g., quality
scores% 50, allelic imbalanceR 0.75, long homopolymer
runs > 3, and/or low quality by depth < 5). Variant data
were annotated with the SeattleSeq Annotation Server.
Variants identified in dbSNP v.134 or in 1,200 exomes
from a subset of the National Heart, Lung, and Blood
Institute (NHLBI) Exome Sequencing Project (ESP) were
excluded prior to analysis for all sequenced individuals.
Analysis of annotated WGS variants in family A
(Figure 1) revealed in the 82 Mb region 15 homozygous
variants shared identically by descent between the affected
aunts (IV-5 and IV-6). Limiting the search to the 16.7 Mb
haplotype that is homozygous and shared between the
affected aunts and heterozygous in the proband (V-1)
reduced the number of candidate genes with predicted
functional variants to four (ECEL1 [MIM 605896], ALPPL2
[MIM 171810], CHRNG, TRIP11 [MIM 604505]). Examina-
tion of each of these four genes for variants in the affected
individuals in the two additional families that underwent
WGS revealed variants shared in only a single gene,
ECEL1 (RefSeq accession number NM_004826.2), in the
affected sibling (II-3) of the proband of family B (Fig-
ure S2). Specifically, in exon 2, the affected aunt (IV-5) in
family A was homozygous for a c.716dupA (p.Tyr239*)
variant predicted to cause a frameshift resulting in an
immediate stop codon, whereas the affected sibling inan Journal of Human Genetics 92, 150–156, January 10, 2013 153
1 5432 76 8 13129 14 15 1710 11 18
c.716dupA
c.344_355del
c.590G>A
c.1252C>A
c.1252C>T
c.1184+3A>T
†
†
†
†
†
†
†
Cytoplasmic
Lumenal/Extracellular 
Transmembrane 
16
Zinc Binding/Activation Site
H  -  E  -  L  -  T  -  H
612-616aa
Activation Site 
Zinc Binding Site Zinc Binding Site 
c.797_801delinsGCT
†c.869A>G
c.1184G>A
Figure 2. Genomic Structure and Allelic Spectrum of ECEL1 Mutations that Cause DA5D
ECEL1 is composed of 18 exons that encode UTRs (orange) and protein-coding-sequence domains (blue), including cytoplasmic (red),
transmembrane (orange), and extracellular (gold) domains and the activation site (black). Arrows indicate the locations of nine different
mutations found in five families affected by DA5D. The † symbol indicates mutations that were confirmed to be inherited from the
parents.family B (II-3) was a compound heterozygote for amissense
mutation (c.869A>G [p.Try290Cys]) in exon 4 and a
5 bp deletion and 3 bp insertion (c.797_801delinsGCT
[p.Asp266Glyfs*15]) predicted to result in a frameshift in
exon 3 (Table 1 and Figure 2). Furthermore, Sanger
sequencing of ECEL1 in the proband in family A (V-1)
found that he inherited the c.716dupA mutation from
his mother (IV-4) and additionally inherited a 12 bp
in-frame deletion (c.344_355del [p.Asn115_Ala118del])
in exon 2 from his father (IV-3). Accordingly, as suspected
from the linkage analysis of family A, DA5D was caused by
homozygosity of a c.716dupA variant in ECEL1 in the
offspring of the consanguineous mating between III-4
and III-5, and although the proband (V-1) inherited only
a single c.716dupA variant from his carrier mother, his
father was by chance a carrier for a different pathogenic
variant in ECEL1.
To determine the extent to which ECEL1 mutations
explain cases of DA5D, we used Sanger sequencing to
screen four additional unrelated families (with a total of
six affected individuals). These families consisted of two
trios and two families with two affected siblings each
(Figure S2). We identified ECEL1 mutations in three fami-
lies (D, E, and F in Table 1 and Figure S2). Each of the
affected individuals in families D and F was compound
heterozygous for predicted functional variants in ECEL1,
whereas the affected proband in family E was homozygous
for a c.1184G>T (p.Arg395Gln) missense variant. Collec-
tively, between the three families used for discovery and
the four families used for validation studies, ECEL1 muta-154 The American Journal of Human Genetics 92, 150–156, January 1tions were found in five out of seven (70%) tested kindreds,
which included three of five families with more than one
affected individual (60%) and two of two simplex cases
(100%). In each of the five families for which DNA was
available from one or both parents, heterozygosity for
the ECEL1 mutation was found. In total, nine unique
mutations, including five missense mutations, two frame-
shifts, one in-frame deletion, and one splicing mutation,
were identified (Table 1 and Figure 2). None of the ECEL1
missense or splice-site mutations identified in the subjects
were found in >13,000 chromosomes sequenced as part of
the NHLBI ESP. The clinical characteristics of individuals
with DA5D caused by ECEL1 mutations were indistin-
guishable from those of individuals without ECEL1 muta-
tions. Additionally, no heterozygous pathogenic ECEL1
variants were found in 20 tested families affected by domi-
nantly inherited DA5.
ECEL1 encodes endothelin-converting enzyme-like 1
(ECEL1) or damage-induced neuronal endopeptidase, a
membrane-bound metalloprotease that, despite its struc-
tural similarity to endothelin-converting enzyme (ECE),
does not cleave ECE substrates.10 In mice, absence of
Ecel1 perturbs the terminal branching of motor neurons
to the endplate of skeletal muscles, resulting in poor
formation of the neuromuscular junction.11,12 However,
the mechanism by which loss of ECEL1 affects distal
axonal arborization of skeletal muscle remains unknown.
The skeletal muscles affected in Ecel1/ mice include the
diaphragm and intercostal muscles, and Ecel1/ mice die
immediately after birth without taking a breath.11,12 This0, 2013
observation suggests that the restrictive lung disease
observed in some individuals with DA5 might be caused
by similar, although less severe, effects on respiratory
muscles.
Our results suggest that DA5D is genetically heteroge-
neous. ECEL1 is highly homologous to ECE1 (MIM
600423), and an ECE1 C>T missense mutation resulting
in a p.Arg742Cys substitution has previously been re-
ported in an individual with Hirschsprung disease (MIM
142623), dysmorphic facial features, and congenital
contractures of the hands.13 In DA5D-affected families in
which no ECEL1 mutations were identified, we screened
ECE1 but did not identify any pathogenic mutations.
Branching defects similar to those observed in Ecel1/
mice have also been reported in mice deficient in other
genes, such as Pea3.14 Similarly, congenital contractures
have been reported in individuals with mutations in other
genes (e.g., CHRNG) known to contribute to the formation
of the neuromuscular junction. Along this line, both of the
affected aunts in family A (IV-5 and IV-6) were also homo-
zygous for a c.994C>T (p.Arg332Trp) missense (GERP
[genomic evolutionary rate profiling] score of 0.45)
variant in CHRNG8 (RefSeq NM_005199.4). We cannot
exclude that this CHRNG variant contributed to the
phenotype of these two cases, particularly because each
affected sibling had features not found in other DA5D
cases, such as cutaneous syndactyly of the fingers and
scoliosis, which are found in individuals with mutations
in CHRNG. However, the c.994C>T variant has not been
reported in cases of multiple pterygium syndrome, nor
were CHRNG mutations found in other DA5D-affected
families.
In summary, we used linkage analysis and WGS of
a consanguineous pedigree to discover that mutations in
ECEL1 cause DA5D and explain ~70% of cases in our
cohort. This observation suggests that DA5D is genetically
heterogeneous. Our findings further support a role for
ECEL1 in the development of the neuromuscular junction
of human skeletal muscles of both the limbs and the trunk.
Finally, our results distinguish a second developmental
pathway that causes congenital-contracture syndromes.Supplemental Data
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